by Peter Ciszewski | Feb 7, 2018
Sam Falsetti, PhD of Cambridge Biomarketing discusses the role of rare disease advocacy groups.
by Peter Ciszewski | Feb 7, 2018
Jean Tang, MD, PhD is co-founder of PellePharm and serves on the PellePharm board of directors. She is a practicing dermatologist and associate professor of dermatology at Stanford University. Gorlin Syndrome is a rare, genetic, disease characterized by mutations in...
by Peter Ciszewski | Feb 7, 2018
Sanuj K. Ravindran, MD is president and CEO of PellePharm. Dr. Ravindran also serves on the PellePharm Board of Directors, and is CEO-in-Residence with BridgeBio, PellePharm’s parent company.
by Peter Ciszewski | Feb 7, 2018
Roxana Sulica, MD, Associate Professor, Department of Medicine and Director, Pulmonary Hypertension at NYU Langone in New York City discusses the challenges of diagnosing pulmonary arterial hypertension (PAH), a progressive condition that affects the heart and lungs....
by Peter Ciszewski | Jan 31, 2018
Sam Falsetti, PhD of Cambridge Biomarketing provides his company’s view of some of the challenges of diagnosing patients with rare...
